Trial Profile
Denosumab Compared with Alendronate in Osteoporotic Postmenopausal Women Previously Treated with Alendronate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Alendronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 02 Sep 2015 New trial record